Tests for Confounding with Cigarette Smoking in the Association of E-cigarette Use with Respiratory Disorder: 2020 National-Sample Data
Overview
Affiliations
Associations of e-cigarette use with respiratory disorder have been demonstrated but it has been unclear whether these are confounded by current or previous cigarette smoking. We address this question through studying different time frames for e-cigarette use and respiratory disorders in 2020 BRFSS data (N = 214,945). E-cigarette use and combustible cigarette smoking were classified into four categories: Participant never used either (Nonuse); used e-cigarettes/cigarettes but not in the past 30 days (Former Use), used in past 30 days on some days (Nondaily Use), or used past 30 days on all days (Daily Use). Contrasts for e-cigarette status and cigarette status (with nonuse as reference group) were entered with covariates in logistic regression with asthma or COPD as criterion. Stratified analyses of e-cigarette use were also performed for smokers and nonsmokers. In the total sample, results showed independent positive associations with both lifetime and current asthma for Former, Nondaily, and Daily e-cigarette use (mostly p < .0001) and the three cigarette indices. Significant positive associations with COPD were found for the three e-cigarette indices (p < .0001) and all the cigarette indices. Stratified analyses showed significant associations of e-cigarette use with respiratory disorder among nonsmokers as well as among smokers. We conclude that independent associations for former e-cigarette use (controlling for current/former smoking) and significant associations of e-cigarette use with respiratory disorder among nonsmokers indicate these associations are not confounded with cigarette smoking and suggest reverse causation is implausible. Findings for former use are discussed with reference to possible mechanisms including sensitization effects.
Airway Proteotypes of E-Cigarette Users Overlap with Those Found in Asthmatics.
Hickman E, Alexis N, Rager J, Jaspers I Am J Respir Cell Mol Biol. 2024; 70(4):326-328.
PMID: 38557396 PMC: 11478130. DOI: 10.1165/rcmb.2023-0381LE.
Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes.
Glantz S, Nguyen N, Oliveira da Silva A NEJM Evid. 2024; 3(3):EVIDoa2300229.
PMID: 38411454 PMC: 11562742. DOI: 10.1056/EVIDoa2300229.
Issues for Studies on E-cigarettes and Chronic Obstructive Pulmonary Disorder.
Wills T, Xie W, Stokes A Am J Prev Med. 2023; 65(6):1196-1197.
PMID: 37981346 PMC: 11132641. DOI: 10.1016/j.amepre.2023.09.009.